Discrimination of methylated and nonmethylated region of a colorectal cancer related promoter using fluorescence enhancement of gold nanocluster at intrastrand of a 9C-loop

Among epigenetic modifications of DNA, methylation of cytosine at its carbon 5 is the most common mark that is usually associated with gene silencing in human. Determining whether a particular DNA molecule is methylated or not, is an indispensable task in many epigenetic investigations. Presenting detection methods with less labor-intensive and time-consuming procedures has substantial value. Here a facile method based on gold nanocluster (AuNCs) fluorescence enhancement is presented. Target sequences were selected from Sept9 promoter region as its hypermethylation is demonstrated as a reliable biomarker of colorectal cancer. DNA probe was complementary to a 25 nucleotide of the target region and possessed 9 additional cytosines in the middle to allow the formation of AuNCs. Probe-AuNCs strands were first hybridized with methylated and non-methylated targets separately, and then their fluorescence intensities were recorded. Fluorescence intensity was higher with methylated targets than non-methylated one. Applying silver ions reversed the situation and fluorescence intensities of non-methylated DNA got higher than methylated one.

[1]  M. Ganjali,et al.  Fluorescence enhancement of silver nanocluster at intrastrand of a 12C-loop in presence of methylated region of sept 9 promoter. , 2018, Analytica chimica acta.

[2]  Chun-yang Zhang,et al.  Single quantum dot-based nanosensor for sensitive detection of 5-methylcytosine at both CpG and non-CpG sites† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c7sc04813k , 2017, Chemical science.

[3]  Chun-yang Zhang,et al.  A single quantum dot-based nanosensor for the signal-on detection of DNA methyltransferase. , 2017, Chemical communications.

[4]  M. Hosseini,et al.  A new fluorescence turn-on nanobiosensor for the detection of micro-RNA-21 based on a DNA–gold nanocluster , 2017, Methods and applications in fluorescence.

[5]  Morteza Hosseini,et al.  Label free colorimetric and fluorimetric direct detection of methylated DNA based on silver nanoclusters for cancer early diagnosis. , 2015, Biosensors & bioelectronics.

[6]  K. M. Koo,et al.  DNA-bare gold affinity interactions: mechanism and applications in biosensing , 2015 .

[7]  M. Trau,et al.  Highly sensitive DNA methylation analysis at CpG resolution by surface-enhanced Raman scattering via ligase chain reaction. , 2015, Chemical communications.

[8]  Juewen Liu,et al.  DNA-templated fluorescent gold nanoclusters reduced by Good's buffer: from blue-emitting seeds to red and near infrared emitters , 2015 .

[9]  Chia-Wei Wang,et al.  Fluorescent gold nanoclusters: recent advances in sensing and imaging. , 2015, Analytical chemistry.

[10]  H. Renz,et al.  Update on epigenetics in allergic disease. , 2015, The Journal of allergy and clinical immunology.

[11]  Abu Ali Ibn Sina,et al.  Methylsorb: A simple method for quantifying DNA methylation using DNA-gold affinity interactions , 2014, 8th International Conference on Electrical and Computer Engineering.

[12]  Manolis Kellis,et al.  Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci , 2014 .

[13]  Manolis Kellis,et al.  Alzheimery's disease pathology is associated with early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci , 2014, Nature Neuroscience.

[14]  K. Chiam,et al.  Epigenetic biomarkers in prostate cancer: Current and future uses. , 2014, Cancer letters.

[15]  Zsolt Tulassay,et al.  Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island , 2013, BMC Cancer.

[16]  Olivier Blacque,et al.  Crystal structures of B-DNA dodecamer containing the epigenetic modifications 5-hydroxymethylcytosine or 5-methylcytosine , 2013, Nucleic acids research.

[17]  Hongwei Ma,et al.  Label-free real-time detection of DNA methylation based on quartz crystal microbalance measurement. , 2013, Analytical chemistry.

[18]  Mary Goldman,et al.  The UCSC Genome Browser database: extensions and updates 2013 , 2012, Nucleic Acids Res..

[19]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[20]  Lingwen Zeng,et al.  A simple colorimetric detection of DNA methylation. , 2012, The Analyst.

[21]  Mary Goldman,et al.  The UCSC Genome Browser database: extensions and updates 2011 , 2011, Nucleic Acids Res..

[22]  A. Bird,et al.  CpG islands and the regulation of transcription. , 2011, Genes & development.

[23]  Fang Wang,et al.  Double recognition of oligonucleotide and protein in the detection of DNA methylation with surface plasmon resonance biosensors. , 2010, Biosensors & bioelectronics.

[24]  J. Ordovás,et al.  Epigenetics and cardiovascular disease , 2010, Nature Reviews Cardiology.

[25]  Jaroslav Kypr,et al.  Circular dichroism and conformational polymorphism of DNA , 2009, Nucleic acids research.

[26]  Warren A. Kibbe,et al.  The issue of amalgams. , 1996, Nucleic Acids Res..

[27]  Akimitsu Okamoto,et al.  Degradation of DNA by bisulfite treatment. , 2007, Bioorganic & medicinal chemistry letters.

[28]  C. Plass,et al.  Restriction landmark genomic scanning for DNA methylation in cancer: past, present, and future applications. , 2002, Analytical biochemistry.

[29]  Christoph Grunau,et al.  Identification and resolution of artifacts in bisulfite sequencing. , 2002, Methods.

[30]  S. Clark,et al.  High sensitivity mapping of methylated cytosines. , 1994, Nucleic acids research.

[31]  A. Rich,et al.  Molecular structure of (m5 dC-dG)3: the role of the methyl group on 5-methyl cytosine in stabilizing Z-DNA. , 1982, Nucleic acids research.

[32]  M. Behe,et al.  Effects of methylation on a synthetic polynucleotide: the B--Z transition in poly(dG-m5dC).poly(dG-m5dC). , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Peter Ulz,et al.  Circulating tumor DNA as a liquid biopsy for cancer. , 2015, Clinical chemistry.